HPV JAB TRIAL
'Indian' cervical cancer vaccine to hit market soonSingh said Covid-19 had raised awareness about preventive healthcare and the development of vaccines like the one against cervical cancer w...
NTAGI to review trial data on SII's qHPV vaccine against cervical cancerSerum Institute of India Director for Government and Regulatory Affairs Prakash Kumar Singh applied to the Drugs Controller General of Indi...
SII’s cervical cancer vaccine: SEC to review HPV jab trial data todayThe subject expert committee (SEC) under the drug regulator will review the trial data of the vaccine that has been developed by Serum Inst...
- Load More